Cutler Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-46,100
| Closed | -$1K | – | 5041 |
|
|
2019
Q4 | $1K | Buy |
46,100
+17,100
| +59% | +$1.14M | ﹤0.01% | 3875 |
|
|
2019
Q3 | $21K | Sell |
29,000
-600
| -2% | -$23.9K | ﹤0.01% | 2171 |
|
|
2019
Q2 | $110K | Sell |
29,600
-100
| -0.3% | -$3.26K | 0.01% | 1051 |
|
|
2019
Q1 | $71K | Buy |
29,700
+25,000
| +532% | +$589K | 0.01% | 1209 |
|
|
2018
Q4 | $33K | Sell |
4,700
-2,200
| -32% | -$51.2K | ﹤0.01% | 1758 |
|
|
2018
Q3 | $23K | Buy |
6,900
+1,400
| +25% | +$52.7K | ﹤0.01% | 2166 |
|
|
2018
Q2 | $12K | Sell |
5,500
-16,400
| -75% | -$533K | ﹤0.01% | 2573 |
|
|
2018
Q1 | $28K | Sell |
21,900
-18,500
| -46% | -$578K | ﹤0.01% | 2056 |
|
|
2017
Q4 | $192K | Sell |
40,400
-39,100
| -49% | -$1.2M | 0.01% | 989 |
|
|
2017
Q3 | $247K | Sell |
79,500
-17,500
| -18% | -$645K | 0.01% | 1043 |
|
|
2017
Q2 | $471K | Sell |
97,000
-81,600
| -46% | -$3.63M | 0.02% | 726 |
|
|
2017
Q1 | $390K | Buy |
178,600
+126,900
| +245% | +$5.79M | 0.02% | 764 |
|
|
2016
Q4 | $185K | Buy |
51,700
+13,700
| +36% | +$486K | 0.01% | 1350 |
|
|
2016
Q3 | $177K | Buy |
38,000
+11,900
| +46% | +$448K | 0.01% | 1319 |
|
|
2016
Q2 | $172K | Sell |
26,100
-17,800
| -41% | -$628K | 0.01% | 1237 |
|
|
2016
Q1 | $211K | Sell |
43,900
-22,800
| -34% | -$745K | 0.01% | 984 |
|
|
2015
Q4 | $893K | Buy |
+66,700
| New | +$2.52M | 0.05% | 374 |
|
Other funds holding MDCO
Cutler Group's MDCO Position: Q1 2020 in Review
Cutler Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 49,500 shares — an estimated $4.2M sold.
Cutler Group first reported a position in MDCO in Q4 2015 and held it in 17 quarters. The position peaked at $4.42M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Cutler Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Cutler Group sold 49,500 Medicines Co shares in Q1 2020, an estimated $4.2M.
- Cutler Group first reported a position in Medicines Co in Q4 2015 and held it in 17 quarters.
- Cutler Group's Medicines Co position peaked at $4.42M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.